Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Clinical Research & Trials Volume 2 (2017), Article ID 2:IJCRT-111, 4 pages
https://doi.org/10.15344/2456-8007/2017/111
Research Article
Open Label Clinical Trial of Hydrogen Brain Food for 91 Alzheimer's Patients (Targeting Therapy for Homocysteic Acid in Blood is an Alzheimer's Cognitive Recovery)

Tohru Hasegawa1* and Yasubumi Uchida2

1Saga Woman Junior College, Saga 849-8440, Japan
2Saga Memorial Hospital, Takagise, 849-0917, Saga, Japan
Dr. Tohru Hasegawa, Saga Woman Junior College ,1313 Honjomachi Oaza Honjo, Saga, Saga Prefecture 840-8440, Japan; E-mail: ghf238134@leo.bbiq.jp
06 December 2016; 10 January 2017; 12 January 2017
Hasegawa T, Uchida Y (2017) Open Label Clinical Trial of Hydrogen Brain Food for 91 Alzheimer's Patients (Targeting Therapy for Homocysteic Acid in Blood is an Alzheimer's Cognitive Recovery). Int J Clin Res Trials 2: 111. doi: https://doi.org/10.15344/2456-8007/2017/111
© 2017 Hasegawa et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Karran E, Mercken M, De Strooper B (2011) The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10: 698-712 [CrossRef] [Google Scholar] [PubMed]
  2. Snowdon DA (1997) Aging and Alzheimer's Disease: Lessons From the Nun Study. Gerontologist 37: 150-156 [CrossRef] [Google Scholar] [PubMed]
  3. Stern Y (2012) Cognitive reserve in ageing and Alzheimer'sdisease. Lancet Neurol 11: 1006-1012 [CrossRef] [Google Scholar] [PubMed]
  4. Lockhart B, Jones C, Cuisinier C, Villain N, Peyroulan D, et al. (2000) Inhibition of L-homocysteic acid and buthionine sulphoximine-mediated neurotoxicity in rat embryonic neuronal cultures with a-lipoic acid enantiomers. Brain Res 855: 292-297 [CrossRef] [Google Scholar] [PubMed]
  5. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, et al. (2007) Natural Oligomers of the AlzheimerAmyloid-s Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor- Dependent Signaling Pathway. J Neurosci 27: 2866-2875 [CrossRef] [Google Scholar] [PubMed]
  6. Folbergrová J, Jesina P, Drahota Z, Lisý V, Haugvicová R,et al. (2007) Mitochondrial complex Iinhibitionincerebralcortexof immature rats following homocysteic acid-inducedseizures. Exp Neurol 204: 597-609 [CrossRef] [Google Scholar] [PubMed]
  7. Ramos Coutinho M, da Silva LF, Menescal-de-Oliveira L (2008) Modulation of tonic immobility in guinea pig PAG by homocysteic acid, a glutamate agonist. Physiol Behav 94: 468-473 [CrossRef] [Google Scholar] [PubMed]
  8. Beard RS Jr, Reynolds JJ, Bearden SE (2011) Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptordependent regulation of adherens and tight junctions. Blood 118: 2007- 2014 [CrossRef] [Google Scholar] [PubMed]
  9. Vorbrodt AW, Dobrogowska DH, Ueno M, Tarnawski M (1995) A quantitative immunocytochemical study of blood-brain barrier to endogenous albumin in cerebral cortex and hippocampus of senescence-accelerated mice (SAM). Folia Histochem Cytobiol 33: 229-237 [Google Scholar] [PubMed]
  10. Scudellar M (2015) By splicing animals together, scientists have shown that young blood rejuvenates old tissues. Now, they are testing whether it works for humans. Nature 517: 426-429 [View]
  11. Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, et al. (2011) The ageingsystemic milieu negatively regulates neurogenesis and cognitivefunction. Nature 477: 90-4 [CrossRef] [Google Scholar] [PubMed]
  12. Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, et al. (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485: 512-516 [CrossRef] [Google Scholar] [PubMed]
  13. Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, et al. (2015) Blood-Brain Barrier Breakdown in the Aging Human Hippocampus. Neuron 85: 296-302 [CrossRef] [Google Scholar] [PubMed]
  14. Hasegawa T, Ichiba M, Matsumoto SE, Kasanuki K, Hatano T, et al. (2012) Urinary Homocysteic Acid Levels Correlate with Mini-Mental State Examination Scores in Alzheimer’s Disease Patients. J Alzheimer’s Dis 31 59-64 [CrossRef] [Google Scholar] [PubMed]
  15. Hasegawa T, Mikoda N, Kitazawa M, LaFerla FM (2009) B6 deficient feeding or homocysteic acid induces the earlier Alzheimer’s pathological change in normal C57BL male mice. Nature Precedings [Google Scholar]
  16. Hasegawa T, Mikoda N, Kitazawa M, LaFerla FM (2010) Treatment of Alzheimer’s disease with anti-homocysteicacid antibody in 3xTg-AD male mice. PLoS One 5: e8593 [CrossRef] [Google Scholar] [PubMed]
  17. Hasegawa T, Ukai W, Jo DG, Xu X, Mattson MP, et al. (2005) Homocysteic acid induces intraneuronal accumulation of neurotoxic Abeta42: Implication for the pathogenesis of Alzheimer’s disease. J Neurosci Res 80: 869-876 [CrossRef] [Google Scholar] [PubMed]
  18. Miller RD, Monsul NT, Vender JR, Lehmann JC (136) NMDA- and endothelin-1-induced increases in blood-brain barrier permeability quantitated with Lucifer yellow. J Neurol Sci 136: 37-40 [CrossRef] [Google Scholar] [PubMed]
  19. Do KQ, Herrling PL, Streit P, Cuenod M (1988) Release of neuroactive substances: homocysteic acid as an endogenous agonist of the NMDA receptor. J Neural Transm 2: 185-190 [CrossRef] [Google Scholar] [PubMed]
  20. Eichenbaum H (2004) Hippocampus: Cognitive Processes and Neural Representations that Underlie Declarative Memory. Neuron 44: 109-122 [CrossRef] [Google Scholar] [PubMed]
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.